Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$27,000.00
Investigating strategies to accelerate evidence generation and delivery to inform clinical decision-making in gastrointestinal oncology
EF 2024-25
Résumé
Gastrointestinal oncology is increasingly in need of evidence that can be created and used quickly. Because of rapid advancements in medicine and technology, new treatments, ways to monitor cancer growth and organized cancer screening programs aimed to improve patient outcomes are quick to emerge. At the same time, these advancements have created new challenges needing new answers. Generally, randomized clinical trials are considered the best method for finding these answers, but they often take too long before the evidence can be used for patients in immediate need. This issue has led to new strategies that create evidence quickly so new treatments can be used in patient care sooner. Computer simulation models have been developed to predict how new screening tests can decrease cancer risk in future years. Clinical trials can use indicators that measure a new drug's effectiveness earlier so it can be approved and used in patient care sooner. Electronic methods of signing consent forms for participation in research studies can speed up the time needed to enrol enough study participants. Quick blood tests have been developed to determine if a treatment is working early and to make decisions about further treatment. This thesis will evaluate these strategies in the prevention and treatment of gastrointestinal cancers. In four separate sections, this thesis will use computer modelling to assess new colorectal cancer screening guidelines in Canada, review indicators used in clinical trials to show a drug's ability to treat gastrointestinal cancers, evaluate patient preferences for electronic consenting methods in research studies, and examine if blood testing technology can predict early if treatment is working for patients with pancreatic cancer.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
530388
Name
Chia Brendan J
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating strategies to accelerate evidence generation and delivery to inform clinical decision-making in gastrointestinal oncology
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Circulating Tumour Dna; Colorectal Cancer Screening; Gastro-Intestinal Oncology; Health Policy; Healthcare Resource Allocation; Microsimulation Modeling; Next Generation Genomic Sequencing; Precision Medicine; Predictive Biomarkers; Surrogate Endpoint Validation
Abstract
Gastrointestinal oncology is increasingly in need of evidence that can be created and used quickly. Because of rapid advancements in medicine and technology, new treatments, ways to monitor cancer growth and organized cancer screening programs aimed to improve patient outcomes are quick to emerge. At the same time, these advancements have created new challenges needing new answers. Generally, randomized clinical trials are considered the best method for finding these answers, but they often take too long before the evidence can be used for patients in immediate need. This issue has led to new strategies that create evidence quickly so new treatments can be used in patient care sooner. Computer simulation models have been developed to predict how new screening tests can decrease cancer risk in future years. Clinical trials can use indicators that measure a new drug's effectiveness earlier so it can be approved and used in patient care sooner. Electronic methods of signing consent forms for participation in research studies can speed up the time needed to enrol enough study participants. Quick blood tests have been developed to determine if a treatment is working early and to make decisions about further treatment. This thesis will evaluate these strategies in the prevention and treatment of gastrointestinal cancers. In four separate sections, this thesis will use computer modelling to assess new colorectal cancer screening guidelines in Canada, review indicators used in clinical trials to show a drug's ability to treat gastrointestinal cancers, evaluate patient preferences for electronic consenting methods in research studies, and examine if blood testing technology can predict early if treatment is working for patients with pancreatic cancer.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Chia, Brendan J
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~